Results 191 to 200 of about 370,832 (346)

Early type I IFN blockade improves the efficacy of viral vaccines. [PDF]

J Exp Med, 2020
Palacio N, Dangi T, Chung YR, Wang Y, Loredo-Varela JL, Zhang Z, Penaloza-MacMaster P.   +6 more
europepmc   +1 more source

CD147/Basigin: From Integrative Molecular Hub to Translational Therapeutic Target

Advanced Science, EarlyView.
This review conceptualizes CD147 as a fundamental “Energy‐Structure Coupler,” physically bridging metabolic flux (via MCTs) with morphogenetic plasticity (via integrins/MMPs) to drive cancer, infection, and autoimmunity. Addressing the “specificity paradox” that limits current translation, the authors chart a strategic roadmap—spanning logic‐gated ...
Xiang‐Min Yang, Huijie Bian, Zhi‐Nan Chen   +2 more
wiley   +1 more source

Viral Vaccines as an Alternative to Antimicrobials: A Perspective from Swine Veterinarians on Challenges, Opportunities, and Future Directions. [PDF]

Pathogens
Li D, Zhang X, Apley MD, Gebhardt JT, Karriker L, Connor JF, Bromfield C, Lubbers B, Kittana H, Pendell D, Madera R, Muro N, Craig A, Shenkenberg B, Li Y, Wang L, Shi J.   +16 more
europepmc   +1 more source

Using the Past to Maximize the Success Probability of Future Anti-Viral Vaccines. [PDF]

Vaccines (Basel), 2020
Serwer P.
europepmc   +1 more source

Influenza Epidemiology and Vaccine Effectiveness among Patients with Influenza-Like Illness, Viral Watch Sentinel Sites, South Africa, 2005–2009

, 2014
Genevie Ntshoe, Johanna M. McAnerney, Stefano Tempia, Lucille Blumberg, Jocelyn Moyes, Amelia Buys, Dhamari Naidoo, Marietjie Venter, Terry G. Besselaar, Barry D. Schoub, Bernice N. Harris, Cheryl Cohen   +11 more
openalex   +2 more sources

Relationship Between Knowledge and Compliance With Safety Measures: Evidence From COVID‐19

Applied Economic Perspectives and Policy, EarlyView.
ABSTRACT Compliance with health safety protocols is important for protecting public health, particularly in agricultural sectors where disease outbreaks can disrupt production and market access. Despite its economic significance, we know little about what drives protocol compliance.
Nilufer Cetik, Carola Grebitus, Lauren Chenarides   +2 more
wiley   +1 more source

Artificial Intelligence Driven Framework for the Design and Development of Next-Generation Avian Viral Vaccines. [PDF]

Microorganisms
Goud MD, Ramos E, Shah AU, Hemida MG.
europepmc   +1 more source

Computational design and evaluation of a polyvalent vaccine for viral nervous necrosis (VNN) in fish to combat Betanodavirus infection

Abu Tayab Moin, Nurul Amin Rani, Yasin Arafath Sharker, Tanbir Ahammed, Umme Sadea Rahman, Sangida Yasmin, Irfan Haque Ratul, Shanjida Akter Joyoti, Muhammad Musa, Mizan Ur Rahaman, Dipankar Biswas, Md. Hazrat Ali, S. M. Murshid Ul Alam, Rajesh B. Patil, Rashed Nabi, Mohammad Helal Uddin   +15 more
openalex   +1 more source

Rethinking Power Solutions for Healthcare Wearables: From Point‐of‐Care and Episodic use to Continuous Monitoring and Therapeutic Platforms

Advanced Energy and Sustainability Research, EarlyView.
This Perspective examines practical power solutions for wearable healthcare systems, highlighting the limits of standard batteries. It categorizes wearables into four domains—point‐of‐care diagnostics, episodic monitoring, continuous long‐term monitoring, and therapeutic platforms—and analyzes their power needs.
Seokheun Choi
wiley   +1 more source

Harnessing co-operative immune augmentation by contact allergens to enhance the efficacy of viral vaccines. [PDF]

Contact Dermatitis, 2020
Cunningham LS, McFadden JP, Basketter DA, Ferguson FJ, White IR, Kimber I.   +5 more
europepmc   +1 more source